Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

Published: Apr-2014 | Format: PDF | GlobalData | Number of pages: 181 | Code: MRS - 24008


GlobalData's clinical trial report, "Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent Malignant Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Recurrent Malignant Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Recurrent Malignant Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Recurrent Malignant Glioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Recurrent Malignant Glioma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Recurrent Malignant Glioma Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Insys Therapeutics, Inc. 33
Clinical Trial Overview of Insys Therapeutics, Inc. 33
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
TransMolecular, Inc. 36
Clinical Trial Overview of TransMolecular, Inc. 36
Eli Lilly and Company 37
Clinical Trial Overview of Eli Lilly and Company 37
to-BBB technologies BV 38
Clinical Trial Overview of to-BBB technologies BV 38
Tactical Therapeutics, Inc 39
Clinical Trial Overview of Tactical Therapeutics, Inc 39
Shandong Lanjin Pharmaceuticals Co. Ltd 40
Clinical Trial Overview of Shandong Lanjin Pharmaceuticals Co. Ltd 40
Direct Therapeutics, Inc. 41
Clinical Trial Overview of Direct Therapeutics, Inc. 41
Amgen Inc. 42
Clinical Trial Overview of Amgen Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
National Cancer Institute 43
Clinical Trial Overview of National Cancer Institute 43
Duke University 45
Clinical Trial Overview of Duke University 45
Memorial Sloan Kettering Cancer Center 47
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 47
North American Brain Tumor Consortium 48
Clinical Trial Overview of North American Brain Tumor Consortium 48
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Northwestern University 50
Clinical Trial Overview of Northwestern University 50
UCLA's Jonsson Comprehensive Cancer Center 51
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 51
Sidney Kimmel Comprehensive Cancer Center 52
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 52
University of Colorado 53
Clinical Trial Overview of University of Colorado 53
Wake Forest University 54
Clinical Trial Overview of Wake Forest University 54
Five Key Clinical Profiles 55
Appendix 178
Abbreviations 178
Definitions 178
Research Methodology 179
Secondary Research 179
About GlobalData 180
Contact Us 180
Disclaimer 180
Source 181

List of Tables

Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Recurrent Malignant Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Recurrent Malignant Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Recurrent Malignant Glioma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Recurrent Malignant Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Recurrent Malignant Glioma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Recurrent Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Recurrent Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Recurrent Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Recurrent Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Recurrent Malignant Glioma Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Recurrent Malignant Glioma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Recurrent Malignant Glioma Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Recurrent Malignant Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Insys Therapeutics, Inc., 2014* 33
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 34
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 35
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by TransMolecular, Inc., 2014* 36
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 37
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by to-BBB technologies BV, 2014* 38
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tactical Therapeutics, Inc, 2014* 39
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong Lanjin Pharmaceuticals Co. Ltd, 2014* 40
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Therapeutics, Inc., 2014* 41
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 42
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 43
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 45
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 47
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by North American Brain Tumor Consortium, 2014* 48
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 49
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 50
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014* 51
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014* 52
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2014* 53
Recurrent Malignant Glioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014* 54

List of Figures

Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Recurrent Malignant Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Recurrent Malignant Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Recurrent Malignant Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Recurrent Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Recurrent Malignant Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Recurrent Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Recurrent Malignant Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Recurrent Malignant Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Recurrent Malignant Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Recurrent Malignant Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 179

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing